QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.

Press

22Apr 2021

Quantify supports nonprofit organization Majblomman

Everyone is affected by the ongoing pandemic, especially the most vulnerable of us. Therefore, Quantify has decided to make a donation to Majblomman, a nonprofit organisation with the mission to decrease the impact of child poverty in Sweden.

Majblomman’s work is usually financed by thousands of children that sell “majblomman” – a small flower pin – each year in April. This year […]

21Apr 2021

Findings from Nordic RWE study BISCUITS

Quantify’s Sara Hallberg, Emilie Toresson Grip & Johan Liseth Hansen are participating authors on the poster presenting one of the most comprehensive Nordic RWE studies on the economic burden of osteoarthritis conducted to date.

The BISCUITS study presented at ISPOREurope found people with osteoarthritis incurred over 60% the average annual costs compared to people without OA, including costs of primary care, productivity loss, specialist care and drugs. Learn more from […]

15Apr 2021

Lead Analyst Christoph Abé joins Quantify

Last week we got to welcome another superstar to the team – Christoph Abé, our new Lead Analyst. Christoph has a PhD in biophysics and many years of experience within health care, psychiatry, and clinical research. He will strengthen our crew as a problem solver with a broad scientific knowledge in data analysis, statistics, programming, and neuroscience.

Quantify Research provides high quality and real-world evidence-based research services, which are essential […]

15Apr 2021

BISCUITS – one of the largest Nordic RWE studies on osteoarthritis

Quantify’s Sara Hallberg, Emilie Toresson Grip & Anders Gustavsson are participating authors of one of the largest Nordic RWE studies on osteoarthritis (OA) conducted to date. The BISCUITS study includes all OA patients identified in specialist care in the Nordic countries, linking data on specialty and primary care, drug use, work absence, socioeconomics, pain severity and quality of life for patients and matched controls from the general population.

Graph backpain osteoarthritis […]